While founded in 2018, Scripx launched its services at the beginning of 2020, after building out its platform and getting the proper certifications to operate a pharmacy from the state of Texas. And like many operating in the telehealth space, the company has been seeing rapid growth.
However, the pandemic has caused Scripx to pivot its business model, growing from focusing on landing physician practices and other health care facilities as clients to focusing on gaining individual customers. Largely, Scripx is focused on the Baby Boomer Generation, which ages require more medications, and Millennials, who are used to more used to on-demand services.
“In terms of COIVD, you hate to say there’s a silver lining to everything, but it really played into our business model and our vision and our mission of basically creating healthier futures in a more affordable and accessible way,” Jon Eaton, Scripx CEO said. “It forced people if they weren’t going to look at it initially, to start looking at it now.”
As new players and enterprise companies enter the telehealth space, Scripx sees new opportunities for its own growth. Eaton said more companies operating in the space helps draw more attention to it and prove its validity as a business model. Besides, he said he sees partnership opportunities with other health care companies, like those operating in generic drug manufacturing. The company has recently partnered with local ride-hailing startup Alto to deliver prescriptions to customer’s doorsteps.
“The way I look at it is there are so much market cap and space just in the state of Texas, you could even say just in the Metroplex, that if I do it right in my area and I perfect my model, or I come up with one or two differentiators that the other guys don’t do, at some point, they’re going to come to talk to me you know merger acquisition or some joint venture,” Eaton said. “And so if they want to spend all the big marketing dollars educating the public on this type of model, then I can just follow that and be more of the local guy and be the good guy at what I do.”
In addition to partnership opportunities, Scripx has internal plans for growth. The company is looking to build out its technology, infrastructure, and eight-person team, focusing on gaining more traction in the DFW market before expanding into other major Texas cities around the beginning of 2022. In the meantime, Scripx has plans to add new medications to its platform, streamline its delivery service and create more personalized options for its technology.
“If you don’t adapt or evolve with what we’re doing because we're moving so fast, you’re going to die on the vine,” Eaton said.
A previous version of this story contained erroneous information provided by the CEO.
